• SENSEX 81,411.35
    -499.66 (--0.61%)
  • BANKNIFTY 61,518.50
    726.10 (+1.19%)
Back

Corporate News

Nath Bio-Genes to review financial results at board meeting November 14, 2026
07-Nov-2026, 12:44

Nath Bio-Genes (India) Limited will hold a board meeting on Saturday, November 14, 2026, to approve the unaudited financial results for both standalone and consolidated entities for the quarter and half year ended September 30, 2026, in compliance with Regulation 29 and 33 of the SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015; the company closed its trading window for insider trading prevention from September 30, 2026, and it will reopen on November 17, 2026.